News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Adrelia Allen: ASCO25 Highlights – Meaningful Discussions on Clinical Trial Diversity
Adrelia Allen/LinkedIn
Jun 7, 2025, 12:30

Adrelia Allen: ASCO25 Highlights – Meaningful Discussions on Clinical Trial Diversity

Adrelia Allen, Executive Director, Clinical Trial Patient Diversity at Merck, shared a post on LinkedIn:

“At ASCO25, I was inspired by the meaningful dialogue shared by a dedicated group of oncology leaders and advocates who came together to discuss how we can expand access and representation in clinical trials.
A special thank you to my colleague Marjorie Green for opening the session with a clear call to action: our clinical trials must reflect the populations our medicines and vaccines are designed to help. Representation in research isn’t just a moral imperative – it’s essential to building trust, advancing science and accelerating access to care that truly meets the needs of people with cancer.
Grateful to the panelists and moderator M. Catherine Pietanza for their valuable insights and continued leadership:
– Rob Winn – VCU Massey Comprehensive Cancer Center
– Nadine Barrett – Wake Forest School of Medicine​
– Ruben Mesa – Atrium Health Levine Cancer Center
– Camille (Pope) Campbell – Acclinate
Lastly, thank you to A. Amanda Bishop and Michelle Chawla for bringing this conversation to ASCO25.”

Read OncoDaily’s Special Articles from ASCO25: 

Highlights from ASCO 2025 Day 1

Highlights from ASCO 2025 Day 2

Highlights from ASCO 2025 Day 3

Highlights from ASCO 2025 Day 4

Clifford Hudis ASCO25

A. Amanda Bishop Adrelia Allen ASCO 2025 ASCO25 Camille (Pope) Campbell cancer Clinical trial diversity M. Catherine Pietanza Marjorie Green Michelle Chawla Nadine Barrett OncoDaily Oncology Rob winn Ruben Mesa separated by commas: Adrelia Allen Sure! Here are all the names mentioned in the post
Special Coverage
Insight
Jul 19, 2025, 18:31
Kohei Shitara: A My Great Honor to Write the Editorial for the Pivotal MATTERHORN Study
Insight
Jul 19, 2025, 18:12
Corinne Faivre-Finn: Surgery or Radiotherapy for Early-Stage Lung Cancer?
Blog
Jul 19, 2025, 17:49
Habib Nehmé: The U.S. Market Remains Elekta’s Most Strategic and Significant One
Career
Jul 19, 2025, 17:37
Jill Barnholtz-Sloan Has Been Appointed Chief Administrative Officer and Associate Director at Winship Cancer Institute
Blog
Jul 19, 2025, 17:27
Thor Halfdanarson: What's on My NET PubMed Radar
Science
Jul 19, 2025, 17:26
Myeloma Paper of the Day, July 19th, Suggested by Robert Orlowski
Blog
Jul 19, 2025, 16:59
Walid Kamoun: The Evolution of Survival Rates for Lung Adenocarcinoma Over The Past 20 Years
Blog
Jul 19, 2025, 16:48
Eric Small: My Presidential Theme for 2025-2026
Blog
Jul 19, 2025, 16:41
What Makes the SIOP Congress So Special?
Blog
Jul 19, 2025, 16:35
Alisher Kahharov: An Exceptional Experience Visiting the Private Practice of Benjamin Sarfati
Career
Jul 19, 2025, 16:20
Maria do Céu Diniz Borborema Celebrates Winning the SLAOP Young Oncologist Award
Career
Jul 19, 2025, 16:08
Stephanie Graff is the New Associate Director of Global Oncology and Policy at Legorreta Cancer Center at Brown University